CMS Newsroom

Medicare Advantage and Medicare Prescription Drug Programs Expected to Remain Stable in 2026 The Centers for Medicare & Medicaid Services (CMS) is announcing that average premiums, benefits, and plan choices […]

By: Marilyn Schultz

Medicare Advantage and Medicare Prescription Drug Programs Expected to Remain Stable in 2026

The Centers for Medicare & Medicaid Services (CMS) is announcing that average premiums, benefits, and plan choices for Medicare Advantage (MA) and the Medicare Part D prescription drug program are expected to remain stable in 2026. Average premiums are projected to decline in both the MA and Part D programs from 2025 to 2026. CMS is committed to ensuring these programs work for Medicare beneficiaries while maintaining access to high-quality, affordable healthcare options, safeguarding taxpayer dollars, and making sure beneficiaries have the information they need to make informed choices about what is best for them. [Read Full Release]

< Previous All Blogs Next >

Connect with our Team

614-763-2255

You can also fill out this form and we will reach out to you as soon as possible!

By clicking the submit button, I expressly consent by electronic signature to receive communications by telephone, by email, or by text message from Cornerstone Senior Marketing at the telephone number above (even if my number is currently listed on any state, federal, local, or corporate Do Not Call list) including my wireless number if provided. Carrier message and data rates may apply. I understand that my consent is not required as a condition of purchasing any goods or services and that I may revoke my consent at any time. I also acknowledge that I have read and agree to the Privacy Policy and Terms & Conditions. If you do not want to share your information, please click on Do Not Sell My Information for more details.